Bio-Change, Ltd.


BioChange is dedicated to advancing tissue repair and regeneration through innovative technologies. Their flagship CellFoam™ technology provides a natural protein foam scaffold that supports cell growth and tissue repair, with applications in both veterinary and human medicine. The company aims to address unmet medical needs and improve overall well-being by developing products that facilitate natural healing processes.

Industries

biotechnology
health-care

Nr. of Employees

small (1-50)

Bio-Change, Ltd.

Yoqne`am `illit, HaZafon, Israel, Asia


Products

ReGum-Vet

A ready-to-use biodegradable three-dimensional dry foam scaffold composed of cross-linked gelatin for filling and augmentation of periodontal defects in veterinary patients; supplied in multiple shapes and reconstituted prior to placement.

VetFoam

An injectable enzymatically cross-linked gelatin foam scaffold intended to fill and support urethral tissue to treat urinary incontinence in female dogs; designed to solidify in situ and biodegrade over time while supporting continence.

Vitaloc

A powder mix of gelatin and crosslinking enzyme that acts as a hemostatic agent for medium-to-severe bleeding in oral and maxillofacial surgical procedures; powder is wetted by blood and crosslinks into a stable biodegradable matrix.

Revolette

A scaffold-based product described for skin rejuvenation in aesthetic and plastic surgery applications, derived from the same gelatin foam matrix platform and evaluated in preclinical studies.


Services

Commercial supply of veterinary regenerative scaffold products

Direct sales and distribution of biodegradable scaffold implants and injectable scaffolds for veterinary use via online ordering and practice supply.

Collaborative preclinical and clinical research partnerships

Partnerships and collaborations with academic and medical institutions for funding, preclinical studies, and translational research supporting product development.

Expertise Areas

  • Regenerative biomaterials
  • Scaffold-based tissue engineering
  • Veterinary clinical study design and execution
  • Injectable biomaterial therapies
  • Show More (4)

Key Technologies

  • Cross-linked gelatin foam scaffolds
  • Enzymatic cross-linking of gelatin
  • Injectable foam scaffold delivery
  • In-situ blood-activated crosslinking hemostat
  • Show More (3)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.